BioSpace News Archive

KBP-5074 Being Evaluated for the Treatment of Uncontrolled Hypertension in Advanced Chronic Kidney Disease (CKD) Patients Top-Line Data on Track for Fourth Quarter of 2020

Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that Michael Bonney, Executive Chair, will participate in a fireside chat at the virtual Canaccord Genuity 40 th Annual Growth Conference on Thursday, August 13, 2020 at 3:30 p.m. ET. A live webcast will be available in the Investors & Media

RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the appointment of Phyllis Loud Gray as Vice President of Human Resources. “Phyllis brings a wealth of expertise and knowledge in implementing strategi

Versant Ventures today announced the debut of Matterhorn Biosciences AG, a biotechnology company developing T cell receptor therapies based on the recent discovery of MR1T cells that

IQVIA™ announced that Nancy Dreyer, chief scientific officer and senior vice president, Real World Solutions, has been awarded PharmaVOICE magazine’s Red Jacket honor after she was recognized multiple times as a PharmaVOICE 100.

Ideal for Cell and Gene Therapy and COVID-19 research, BioStore IIIv provides improved thermal stability for stored materials, risk mitigation advantages and processes which are documented and repeatable [05-August-2020] CHELMSFORD, Mass. , Aug. 5, 2020 /PRNewswire/ -- Brooks Life Sciences , a division of Brooks Automation, today announced the immediate availabilit

Vyripharm International, Inc., is a subsidiary of Vyripharm Enterprises, LLC, a privately held company formed for Partnerships and Joint Ventures with International Public or Private Organizations.

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its management team will participate virtually in the BTIG Biotechnology Conference on Monday, August 10, 2020 at 12:30 p.m. EDT. To access a live webcast of the fireside chat on the “Investor Relations” page of Entera’s website, please click here . A replay of the webcast will be archived on Entera’

Beckman Coulter announced new analysis from the pivotal study of its novel monocyte distribution width hematologic biomarker for sepsis detection.